Skip to main content
Plasma pseudouridine levels reflect body size in children on hemodialysis.
Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium study.
Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.
Association between BMI changes and mortality risk in children with end-stage renal disease.
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <?6 years with chronic kidney disease receiving dialysis.
Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <?6 years with chronic kidney disease receiving dialysis.
Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease.
Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease.
COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.